Blue Jay Capital Management as of June 30, 2016
Portfolio Holdings for Blue Jay Capital Management
Blue Jay Capital Management holds 14 positions in its portfolio as reported in the June 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Neurocrine Biosciences (NBIX) | 9.1 | $14M | 306k | 45.45 | |
| Seattle Genetics | 8.7 | $13M | 328k | 40.41 | |
| Mead Johnson Nutrition | 8.1 | $12M | 135k | 90.75 | |
| BioMarin Pharmaceutical (BMRN) | 7.8 | $12M | 152k | 77.80 | |
| Masimo Corporation (MASI) | 7.5 | $12M | 219k | 52.52 | |
| Abiomed | 7.5 | $12M | 105k | 109.29 | |
| Boston Scientific Corporation (BSX) | 7.2 | $11M | 470k | 23.37 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 7.1 | $11M | 126k | 86.02 | |
| Ironwood Pharmaceuticals (IRWD) | 7.0 | $11M | 821k | 13.07 | |
| Molina Healthcare (MOH) | 6.7 | $10M | 205k | 49.90 | |
| Biogen Idec (BIIB) | 6.3 | $9.7M | 40k | 241.82 | |
| NuVasive | 6.3 | $9.5M | 160k | 59.72 | |
| Allergan | 5.6 | $8.5M | 37k | 231.08 | |
| Shire | 5.0 | $7.6M | 41k | 184.07 |
